As Health Economics Manager, Ebenezer’s primary areas of focus are working with NHS partners, Pharma, Biotech, MedTech companies and academia to develop, adapt and validate health economics deliverables to evaluate the costs and efficacy of novel interventions in different disease areas.
Prior to joining ICHP, Ebenezar worked for Oxford Academic Health Science Network (OAHSN) and later at ICON and NHSP as an independent consultant where he supported Pharma, Biotech and MedTech companies to develop health economics and value communication deliverables to support submissions and access to the NHS. Ebenezar supported many companies to define pathways for new intervention working in collaboration with industry and clinical experts from the NHS.